Prostate cancer characteristics and cancer-specific mortality of Native American patients.
Aged
Combined Modality Therapy
Follow-Up Studies
Humans
Incidence
Male
Middle Aged
Prognosis
Propensity Score
Prostatectomy
/ mortality
Prostatic Neoplasms
/ epidemiology
Radiotherapy
/ mortality
Retrospective Studies
SEER Program
Survival Rate
United States
/ epidemiology
White People
/ statistics & numerical data
American Indian or Alaska Native
/ statistics & numerical data
Journal
Prostate cancer and prostatic diseases
ISSN: 1476-5608
Titre abrégé: Prostate Cancer Prostatic Dis
Pays: England
ID NLM: 9815755
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
08
07
2019
accepted:
23
10
2019
revised:
05
10
2019
pubmed:
7
11
2019
medline:
9
3
2021
entrez:
8
11
2019
Statut:
ppublish
Résumé
Historical epidemiological data indicate that Native American patients may have worse prostate cancer (PCa) characteristics than Caucasian patients (CAP). To test for cancer-specific mortality (CSM) differences among Native American vs. CAP, the most contemporary version of the SEER database (Surveillance, Epidemiology, and End Results database [2004-2016]) was used. Descriptives and time trend analyses focused on a combined cohort of 357,289 Caucasian and Native American PCa patients of all stages. After 1:4 propensity-score (PS) matching for stage, grade, and other patient characteristics, cumulative incidence plots, and competing-risks-regression-models (CRR) were used, with further stratification according to non-metastatic (T Native American patients accounted for 1804 (0.5%) of the study cohort. Native American patients had higher PSA (8 ng/ml vs. 6.3 ng/ml), higher rate of D'Amico high-risk PCa (30.8 vs. 24.8%), higher rate of T3/T4-PCa (5.5 vs. 3.7%), higher rate of N1 stage (4.5 vs. 2.8%), and higher rate of M1 stage (7.5 vs. 3.9%, all p < 0.001) than CAP. In T Native American patients have more unfavorable stage and grade at presentation. However, after adjustment for these characteristics, CSM in Native American patients is not higher than in CAP. In consequence, PCa prognosis does not differ between Native American and Caucasian race. Therefore, efforts should be made to diagnose PCa in Native Americans at an earlier and more favorable stage like in CAP.
Sections du résumé
BACKGROUND
Historical epidemiological data indicate that Native American patients may have worse prostate cancer (PCa) characteristics than Caucasian patients (CAP). To test for cancer-specific mortality (CSM) differences among Native American vs. CAP, the most contemporary version of the SEER database (Surveillance, Epidemiology, and End Results database [2004-2016]) was used.
METHODS
Descriptives and time trend analyses focused on a combined cohort of 357,289 Caucasian and Native American PCa patients of all stages. After 1:4 propensity-score (PS) matching for stage, grade, and other patient characteristics, cumulative incidence plots, and competing-risks-regression-models (CRR) were used, with further stratification according to non-metastatic (T
RESULTS
Native American patients accounted for 1804 (0.5%) of the study cohort. Native American patients had higher PSA (8 ng/ml vs. 6.3 ng/ml), higher rate of D'Amico high-risk PCa (30.8 vs. 24.8%), higher rate of T3/T4-PCa (5.5 vs. 3.7%), higher rate of N1 stage (4.5 vs. 2.8%), and higher rate of M1 stage (7.5 vs. 3.9%, all p < 0.001) than CAP. In T
CONCLUSIONS
Native American patients have more unfavorable stage and grade at presentation. However, after adjustment for these characteristics, CSM in Native American patients is not higher than in CAP. In consequence, PCa prognosis does not differ between Native American and Caucasian race. Therefore, efforts should be made to diagnose PCa in Native Americans at an earlier and more favorable stage like in CAP.
Identifiants
pubmed: 31695139
doi: 10.1038/s41391-019-0184-8
pii: 10.1038/s41391-019-0184-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
277-285Références
Cronin KA, Lake AJ, Scott S, Sherman RL, Noone AM, Howlader N, et al. Annual Report to the Nation on the Status of Cancer, part i: national cancer statistics. Cancer. 2018;124:2785–800.
doi: 10.1002/cncr.31551
Emerson MA, Banegas MP, Chawla N, Achacoso N, Alexeeff SE, Adams AS, et al. Disparities in prostate, lung, breast, and colorectal cancer survival and comorbidity status among Urban American Indians and Alaskan Natives. Cancer Res. 2017;77:6770–6.
doi: 10.1158/0008-5472.CAN-17-0429
Espey DK, Jim MA, Cobb N, Bartholomew M, Becker T, Haverkamp D, et al. Leading causes of death and all-cause mortality in American Indians and Alaska Natives. Am J Public Health. 2014;104 Suppl 3:S303–11.
doi: 10.2105/AJPH.2013.301798
Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (surveillance, epidemiology, and end results) program population-based study. Arch Intern Med. 2002;162:1985–93.
doi: 10.1001/archinte.162.17.1985
Javid SH, Varghese TK, Morris AM, Porter MP, He H, Buchwald D, et al. Guideline-concordant cancer care and survival among American Indian/Alaskan Native patients. Cancer. 2014;120:2183–90.
doi: 10.1002/cncr.28683
Nash SH, Meisner ALW, Zimpelman GL, Barry M, Wiggins CL. Cancer survival among Alaska Native people. Cancer. 2018;124:2570–7.
doi: 10.1002/cncr.31350
Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, et al. Association of black race with prostate cancer-specific and other-cause mortality. JAMA Oncol. 2019;5:975–83.
doi: 10.1001/jamaoncol.2019.0826
Krimphove MJ, Cole AP, Fletcher SA, Harmouch SS, Berg S, Lipsitz SR, et al. Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer. Prostate Cancer Prostatic Dis. 2019;22:125–36.
doi: 10.1038/s41391-018-0083-4
Howlader N, Noone A, Krapcho M, Miller D, Brest A, Yu M, et al. SEER cancer statistics review, 1975–2016. Bethesda, MD: National Cancer Institute; 2018. Based on November 2018 SEER data submission, posted to the SEER web site, April 2019.
Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, et al. A contemporary prostate cancer grading system: a validated alternative to the gleason score. Eur Urol. 2016;69:428–35.
doi: 10.1016/j.eururo.2015.06.046
Bernard B, Muralidhar V, Chen YH, Sridhar SS, Mitchell EP, Pettaway CA, et al. Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer. Cancer. 2017;123:1536–44.
doi: 10.1002/cncr.30503
White MC, Espey DK, Swan J, Wiggins CL, Eheman C, Kaur JS. Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States. Am J Public Health. 2014;104 Suppl 3:S377–87.
doi: 10.2105/AJPH.2013.301673
Henderson JA, Espey DK, Jim MA, German RR, Shaw KM, Hoffman RM. Prostate cancer incidence among American Indian and Alaska Native men, US, 1999–2004. Cancer 2008;113:1203–12.
doi: 10.1002/cncr.23739
Goins RT, Schure MB, Noonan C, Buchwald D. Prostate cancer screening among American Indians and Alaska natives: the health and retirement survey, 1996–2008. Preventing Chronic Dis. 2015;12:E123.
Hoffman RM, Li J, Henderson JA, Ajani UA, Wiggins C. Prostate cancer deaths and incident cases among American Indian/Alaska Native men, 1999–2009. Am J Public Health. 2014;104 Suppl 3:S439–45.
doi: 10.2105/AJPH.2013.301690
Adams SV, Bansal A, Burnett-Hartman AN, Cohen SA, Karnopp A, Warren-Mears V, et al. Cancer treatment delays in American Indians and Alaska Natives enrolled in medicare. J Health Care Poor Underserved. 2017;28:350–61.
doi: 10.1353/hpu.2017.0027
Blue Bird Jernigan V, Peercy M, Branam D, Saunkeah B, Wharton D, Winkleby M, et al. Beyond health equity: achieving wellness within American Indian and Alaska Native communities. Am J Public Health. 2015;105 Suppl 3):S376–9.
doi: 10.2105/AJPH.2014.302447
Wiggins CL, Espey DK, Wingo PA, Kaur JS, Wilson RT, Swan J, et al. Cancer among American Indians and Alaska Natives in the United States, 1999–2004. Cancer. 2008;113:1142–52.
doi: 10.1002/cncr.23734
Espey DK, Jim MA, Richards TB, Begay C, Haverkamp D, Roberts D. Methods for improving the quality and completeness of mortality data for American Indians and Alaska Natives. Am J Public Health. 2014;104 Suppl 3:S286–94.
doi: 10.2105/AJPH.2013.301716
Jim MA, Arias E, Seneca DS, Hoopes MJ, Jim CC, Johnson NJ, et al. Racial misclassification of American Indians and Alaska Natives by Indian Health service contract health service delivery area. Am J Public health. 2014;104 Suppl 3:S295–302.
doi: 10.2105/AJPH.2014.301933